State Street Corp Greenwich Life Sciences, Inc. Transaction History
State Street Corp
- $2.36 Trillion
- Q1 2025
A detailed history of State Street Corp transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, State Street Corp holds 75,208 shares of GLSI stock, worth $846,090. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75,208
Previous 73,208
2.73%
Holding current value
$846,090
Previous $822,000
12.77%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding GLSI
# of Institutions
43Shares Held
1.1MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY309KShares$3.48 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA270KShares$3.04 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA137KShares$1.54 Million0.0% of portfolio
-
Credit Agricole S A87KShares$978,7500.0% of portfolio
-
Northern Trust Corp Chicago, IL84.6KShares$952,1210.0% of portfolio
About Greenwich LifeSciences, Inc.
- Ticker GLSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,848,200
- Market Cap $145M
- Description
- Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...